Ohashi P S, Zinkernagel R M, Leuscher I, Hengartner H, Pircher H
Department of Medical Biophysics, University of Toronto, Ontario, Canada.
Int Immunol. 1993 Feb;5(2):131-8. doi: 10.1093/intimm/5.2.131.
Very little is known about the conformational properties of the MHC molecules that are able to signal positive selection of a given TCR. To try to understand these parameters and to determine whether these requirements are shared with interactions during negative selection and antigen recognition, we have studied selection and antigen recognition of a transgenic TCR (specific for lymphocytic choriomeningitis virus glycoprotein and H-2Db) in the context of two Db mutants, H-2bm13 and H-2bm14. The data showed that the transgenic TCR was not positively selected by the H-2bm14 haplotype but, interestingly, enhanced positive selection was seen in H-2bm13 mice. The transgenic TCR could not be negatively selected in H-2bm13 animals persistently infected with the virus (neonatal virus carrier mice), nor could the transgenic TCR be activated by H-2bm13 infected cells in vivo or in vitro. These experiments show that although a TCR may be selected by a mutant MHC molecule, the corresponding viral antigen cannot be recognized in context of the mutant MHC molecule, as judged by both negative selection and T cell reactivity in vivo and in vitro. The 'enhanced' positive selection occurring in the context of Dbm13 suggests that a different conformation of the MHC molecule is able to select the same TCR and also that various TCR-ligand avidities may permit positive selection.
对于能够发出特定TCR阳性选择信号的MHC分子的构象特性,人们了解甚少。为了试图理解这些参数,并确定在阴性选择和抗原识别过程中的相互作用是否也有这些要求,我们研究了在两种Db突变体H-2bm13和H-2bm14背景下,一种转基因TCR(特异性识别淋巴细胞性脉络丛脑膜炎病毒糖蛋白和H-2Db)的选择和抗原识别情况。数据显示,转基因TCR未被H-2bm14单倍型阳性选择,但有趣的是,在H-2bm13小鼠中观察到了增强的阳性选择。在持续感染病毒的H-2bm13动物(新生病毒携带小鼠)中,转基因TCR不能被阴性选择,在体内或体外,转基因TCR也不能被H-2bm13感染的细胞激活。这些实验表明,尽管TCR可能被突变的MHC分子选择,但根据体内和体外的阴性选择及T细胞反应性判断,相应的病毒抗原不能在突变的MHC分子背景下被识别。在Dbm13背景下出现的“增强”阳性选择表明,MHC分子的不同构象能够选择相同的TCR,而且各种TCR-配体亲和力可能允许阳性选择。